| Medial Septo-Hippocampal Cholinergic Neurons | |
|---|---|
| Allen Atlas ID | CS202210140_3520 |
| Lineage | Neuron > Cholinergic > Basal forebrain > Septal cholinergic |
| Markers | CHAT, SLC18A3 (VAChT), NGF, p75NTR (NGFR) |
| Brain Regions | Medial septum, Diagonal band of Broca, Hippocampus |
| Disease Vulnerability | Alzheimer's Disease, Parkinson's Disease, Down Syndrome |
Medial Septo Hippocampal Cholinergic Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Medial septo-hippocampal cholinergic neurons are a critical population of basal forebrain neurons that provide the primary cholinergic innervation to the hippocampal formation [1]. These neurons form the cornerstone of the septo-hippocampal cholinergic system, which is essential for memory formation, attention, and spatial navigation [2]. Their strategic position in the medial septum and diagonal band of Broca allows them to modulate hippocampal circuitry and influence cognitive function.
The basal forebrain cholinergic system is one of the first neural systems to degenerate in Alzheimer's disease, making these neurons a key focus of research into memory decline and therapeutic interventions [3].
Medial septo-hippocampal cholinergic neurons are located in:
These structures form a continuous band of cholinergic neurons along the basal forebrain.
These neurons project extensively to the hippocampus:
The projections travel via the fimbria-fornix pathway to reach hippocampal targets.
Medial septo-hippocampal cholinergic neurons are essential for [4]:
These neurons contribute to:
Medial septal neurons drive hippocampal theta rhythms:
Acetylcholine modulates synaptic plasticity:
Medial septo-hippocampal cholinergic neurons exhibit:
Medial septo-hippocampal neurons are particularly vulnerable in AD [3][5]:
This degeneration causes:
Cholinergic involvement in PD:
Trisomy 21 leads to:
Current AD treatments target this system:
Experimental approaches include:
Medial Septo Hippocampal Cholinergic Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Medial Septo Hippocampal Cholinergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Basal forebrain cholinergic system in memory. Trends Neurosci, 2018.
Cholinergic degeneration in Alzheimer's disease. Acta Neuropathol, 2019.
Medial septum and hippocampal theta oscillations. Neuroscience, 2020.
Cholinergic modulation of hippocampal plasticity. Neuropharmacology, 2019.
NGF and basal forebrain cholinergic neurons. Exp Neurol, 2018.